Navigation Links
Transformation of Filamentous Fungi by Microprojectile Bombardment

. When at least 107 conidia were plated, colonies with a prototrophic phenotype were found, indicating that the pyrG89 mutation of the pyrimidine auxotrophic A. nidulans strain was successfully complemented by transformation with pRG-1 plasmid DNA (Figure 1). The first transformants were visible 2436 hours after bombardment. After 48 hours, transformants were counted and transferred onto fresh selective plates for further study.

Conidial density was found to be a crucial parameter in optimizating transformation frequency (Figure 2A). In subsequent experiments, 108 conidia were spread on each plate. Further increasing the spore density, overincubation of plates, or prolonged storage of conidial suspensions prior to the transformation experiment resulted in the occurrence of background colonies. Transformants were found under a wide range of helium pressures (8001,600 psi, Figure 2B) with a reduced transformation frequency at 1,600 psi, possibly due to increased cell death. No transformants were produced by bombardment at 400 psi. No significant difference in transformation frequency was observed when M5 (mean diameter 0.4 m), M10 (0.7m) and M17 (1.1 m) tungsten particles were compared (data not shown). Particles made of material other than tungsten were not tested. The addition of an osmotic stabilizer to the media (1 M sorbitol) did not increase the transformation efficiency. This result is consistent with the results of others who reported that fungal spores or mycelia were transformed in the absence of an osmoticum (see references in Table 1).

Microprojectile bombardment resulted in an overall transformation frequency (6 0.5 transformants/g DNA) that was
'"/>

Source:


Page: All 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Highest Possible Transformation Efficiencies for High-Throughput Applications
2. New Competent Cells for Highest Transformation Efficiencies
3. Optimization of Biolistic Transformation Using the Helium-Driven PDS-1000/He System
4. Sub-Micron Gold Particles Are Superior to Larger Particles for Efficient Biolistic Transformation of Organelles and Some Cells
5. Transformation of Nematodes With the Helios Gene Gun
6. Transformation of Filamentous Fungi by High-Voltage Electroporation
7. Detection of Reporter Gene Activity in Cell Cultures and Murine Epidermis After Helios Gene Gun-Mediated Particle Bombardment

Post Your Comments:
(Date:11/5/2009)..., PARSIPPANY, N.J., Nov. 5 DSM Pha...ade a manufacturing alliance with Galenix, Saint J...ed commercial scale manufacturing partner for Gale...SM and Galenix will collaborate on business develo...very technologies, based on the strength of Galeni...
(Date:11/5/2009)..., LYNBROOK, N.Y., Nov. 5 ... a biopharmaceutical company developing first-in-c...ts financial results for the third quarter ended S... that, in September of this year, the FDA,s Arthri... a vote of 12-0, the approval of XIAFLEX(TM) for t...
(Date:11/5/2009)..., AUSTIN, Texas, Nov. 5 SpineSmith...Osteo, Inc. to co-develop a unique scaffold that m...ollowing evaluation of several commercial products...nt, the company believes the GenOsteo scaffold rep...at creates a unique and ideal environment for the ...
(Date:11/4/2009)... This webinar, which will be ...one working in continuous flow chemistry processin...low cell inline using various meso and micro scale...f over 670 publications has been recognized with s...st recently the 2009 Tetrahedron Prize. , ...
Breaking Biology Technology:DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 2Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 2Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 3
...elixis,Inc. (Nasdaq: EXEL ) announced earlier tod...ommitment from Deerfield Management. The arrangeme...ive conference call at 5:00 a.m.,PT/8:00 a.m. ET t...the,discussion, visit the Event Calendar page unde...ay of the conference call will be available until ...
...ne Control, Trait Stacking in ...MOND, Calif., June 5 Dow,AgroSciences LLC and San...today the successful completion of research milest...l License Agreement. These milestones represent,th...DNA-binding protein,(ZFP) technology to the genera...
...C Santa Barbara,s Solid-State Lighting and Energy ...nce of Asturias Award for Technical and Scientific... is presented with a medal and a Joan Miro sculptu...ecipients in each category also share a 50,000 (US...esearch prize is given annually to "the individual...
Other Biology Technology:Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration 2Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration 3Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration 4Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration 5
(Date:11/4/2009)...ewswire-FirstCall/ -- Quest Diagnostics Incorporat...diagnostic testing, information and services, anno...0, 2009, income from continuing operations rose to...60 million, or $0.81 per diluted share, for the th...s were reduced by a $0.03 per share charge associa...
(Date:11/4/2009)...PRNewswire/ -- GenVault Corporation, the leader in...mic discovery, medicine and identification, today ...sident and CEO, will be presenting at the BIOCOM I...d 27th in La Jolla, CA. ,, During the presentat...mpany together with recent customer, technical and...
(Date:11/4/2009)...RNewswire/ -- GenVault Corporation (Carlsbad, CA) ...as joined its Board of Directors. Dr. Brody, the ...ute, is an acclaimed physician-scientist and unive..., Dr. Brody served as president of The Johns Hopki...demy of Engineering and the Institute of Medicine,...
Breaking Biology News(10 mins):Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17GenVault Corporation to Present at the 2009 BIOCOM Investor Conference 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3SYGNIS to Present at the 11th Rodman 26 Renshaw Annual Global Investment Conference 56338 1SYGNIS to Present at the 11th Rodman 26 Renshaw Annual Global Investment Conference 56338 2REGURIN 28R 29 XL 28trospium chloride 29 Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder 56335 1REGURIN 28R 29 XL 28trospium chloride 29 Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder 56335 2REGURIN 28R 29 XL 28trospium chloride 29 Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder 56335 3REGURIN 28R 29 XL 28trospium chloride 29 Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder 56335 4REGURIN 28R 29 XL 28trospium chloride 29 Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder 56335 5Founder of Curidium Launches Elixior an Advisory Company Focused on the Development and Growth of Innovative Personalized Medicine Businesses 56332 1Founder of Curidium Launches Elixior an Advisory Company Focused on the Development and Growth of Innovative Personalized Medicine Businesses 56332 2
...y (ASH TM ) and American Board of Internal Medicin...a new wave of performance evaluation tools for blo...uirements to maintain ABIM certification, ASH and ...rovement Module (PIM), a web-based tool physicians...ment requirement for recertification. Participants...
...is the deadliest form of the disease, with fewer t...ear prognosis for survival. To find out what drive...d to rapidly screen for drugs that might stop IBC... Diego (UCSD), have come up with an unlikely yet ...ble for xenografts. , More properly, it’s a trans...
...s are heading a worldwide research project which c...diarrhoea in children in developing countries. , T... being piloted in four hospitals in India, will of...ms of the disease quickly, cheaply and with little...ications for improving children,s health could be ...
Other Biology News:New tool helps blood specialists improve patient care 2A fisheye view of the deadliest breast cancer 2Hope for major advance in fighting world killer disease 2Hope for major advance in fighting world killer disease 3
Mouse Anti-Catenin, beta, N-terminal (exon 2) Monoclonal Antibody, Unconjugated, Clone BDI710 from Meridian Life Science, Inc.
Anti-CaMKII (Calmodulin-dependent Protein Kinase II) Monoclonal Antibody, Unconjugated, Clone 6G9 (2) from CHEMICON
Rabbit Anti-SLAP-2 Polyclonal Antibody, Unconjugated from Calbiochem
...s ligand immobilization can be coupled with a liga...or to create an affinity matrix of choice. Affi-Ge...rimary amines. Affi-Gel 10 gel couples neutral or ... gel couples acidic proteins with pI less than 6.5...
Biology Products: